In animal studies using different COPD models, blocking CXCR2 inhibited mucus hypersecretion, and goblet cell hyperplasia (Miller et al., 2003; Stevenson et al., 2005; Chapman et al., 2007). Here, CXCR2 is linked to chronic obstructive pulmonary disease.